AMY KLEMANN: Open Payments
NPI 1922828110 · CARMEL, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$946 in 36 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $47 · 2025 $946
Food & beverage: $946
| Company | Payments | Amount |
|---|---|---|
| Paratek Pharmaceuticals, Inc. | 12 | $472 |
| Organogenesis Inc. | 6 | $146 |
| Smith+Nephew, Inc. | 11 | $140 |
| Kerecis Limited | 2 | $70 |
| Surgenex LLC | 1 | $25 |
| BSN Medical Inc | 1 | $25 |
| Urgo Medical North America, LLC | 1 | $24 |
| HARTMANN USA, INC. | 1 | $24 |
| Solventum Corporation | 1 | $20 |
Products named: NUZYRA, APLIGRAF, COLLAGENASE SANTYL, Kerecis SurgiClose, GRAFIX PL, NOVACHOR, SurGraft, JOBST SPORT.
Industry payments across IN — which companies pay providers there.
